id | C00000674 |
---|---|
Name | Luteolin |
CAS RN | 491-70-3 |
Standard InChI | InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H |
Standard InChI (Main Layer) | InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H |
Phytochemical cluster | No. 15 |
---|---|
KCF-S cluster | No. 71 |
By standard InChI | CHEMBL151 |
---|---|
By standard InChI Main Layer | CHEMBL151 |
By LinkDB | C01514 |
---|
By CAS RN | D047311 |
---|
class name | count |
---|---|
rosids | 134 |
asterids | 44 |
eudicotyledons | 18 |
Liliopsida | 5 |
Magnoliophyta | 2 |
Euphyllophyta | 1 |
Spermatophyta | 1 |
family name | count |
---|---|
Fabaceae | 128 |
Lamiaceae | 21 |
Berberidaceae | 14 |
Asteraceae | 11 |
Crassulaceae | 3 |
Convolvulaceae | 2 |
Resedaceae | 2 |
Juncaceae | 2 |
Scrophulariaceae | 2 |
Campanulaceae | 2 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL151 |
CHEMBL1614110
(1)
CHEMBL1741321
(1)
|
1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL151 |
CHEMBL1613992
(1)
CHEMBL1613995
(2)
CHEMBL1738132 (1) |
7 / 44 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | CHEMBL151 |
CHEMBL1249157
(1)
CHEMBL1249158
(1)
CHEMBL1249160 (1) |
0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL151 |
CHEMBL1613842
(1)
|
4 / 2 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL151 |
CHEMBL1738312
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL151 |
CHEMBL2114784
(2)
|
1 / 1 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | CHEMBL151 |
CHEMBL1071606
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL151 |
CHEMBL1014030
(1)
CHEMBL1014033
(1)
CHEMBL1014037 (1) CHEMBL1014038 (1) CHEMBL1008559 (1) |
0 / 3 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL151 |
CHEMBL1614079
(1)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL151 |
CHEMBL1613818
(2)
|
6 / 4 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL151 |
CHEMBL1614076
(1)
|
1 / 1 |
P39900 | Macrophage metalloelastase | M10A | CHEMBL151 |
CHEMBL2051216
(1)
CHEMBL2051222
(1)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL151 |
CHEMBL2051215
(1)
CHEMBL2051221
(1)
|
2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL151 |
CHEMBL1794585
(1)
|
0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | CHEMBL151 |
CHEMBL1285540
(1)
CHEMBL1799589
(1)
|
0 / 1 |
O95271 | Tankyrase-1 | Enzyme | CHEMBL151 |
CHEMBL2341188
(2)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL151 |
CHEMBL1614544
(1)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL151 |
CHEMBL1614361
(1)
|
3 / 2 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL151 |
CHEMBL1023248
(1)
CHEMBL1101617
(1)
|
1 / 1 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL151 |
CHEMBL1613776
(1)
|
3 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL151 |
CHEMBL1071605
(1)
|
1 / 1 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | CHEMBL151 |
CHEMBL832923
(1)
|
1 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL151 |
CHEMBL862675
(1)
CHEMBL862676
(1)
CHEMBL926333 (1) |
0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL151 |
CHEMBL1225717
(1)
CHEMBL1780345
(1)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL151 |
CHEMBL2076249
(1)
|
1 / 0 |
P49327 | Fatty acid synthase | Transferase | CHEMBL151 |
CHEMBL862461
(1)
|
0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL151 |
CHEMBL897015
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL151 |
CHEMBL1614027
(1)
CHEMBL1741325
(1)
|
0 / 1 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | CHEMBL151 |
CHEMBL876996
(1)
|
0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | CHEMBL151 |
CHEMBL876996
(1)
|
0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL151 |
CHEMBL1614067
(3)
|
1 / 2 |
P51570 | Galactokinase | Enzyme | CHEMBL151 |
CHEMBL1613821
(1)
|
1 / 1 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | CHEMBL151 |
CHEMBL2039370
(1)
CHEMBL2039371
(1)
CHEMBL2039372 (1) CHEMBL2039373 (1) CHEMBL2039374 (1) CHEMBL2039375 (1) CHEMBL2039376 (1) CHEMBL2039377 (1) |
0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL151 |
CHEMBL1614166
(1)
|
1 / 0 |
P11387 | DNA topoisomerase 1 | Isomerase | CHEMBL151 |
CHEMBL920762
(1)
CHEMBL920763
(1)
CHEMBL920764 (1) CHEMBL920765 (1) CHEMBL920772 (1) CHEMBL920776 (1) |
0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL151 |
CHEMBL920766
(1)
CHEMBL920767
(1)
CHEMBL920768 (1) CHEMBL920769 (1) CHEMBL919312 (1) CHEMBL919313 (1) |
0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL151 |
CHEMBL1008560
(1)
|
0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | CHEMBL151 |
CHEMBL1100507
(1)
|
0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL151 |
CHEMBL1613800
(2)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL151 |
CHEMBL1614458
(2)
|
0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | CHEMBL151 |
CHEMBL2342404
(1)
|
1 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL151 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL151 |
CHEMBL1794486
(2)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL151 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL151 |
CHEMBL2114843
(1)
CHEMBL2114780
(1)
|
0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | CHEMBL151 |
CHEMBL2114807
(1)
|
4 / 2 |
P09874 | Poly [ADP-ribose] polymerase 1 | Enzyme | CHEMBL151 |
CHEMBL2341185
(2)
|
0 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL151 |
CHEMBL2051212
(1)
|
0 / 1 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL151 |
CHEMBL1794569
(1)
|
1 / 1 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL151 |
CHEMBL1963893
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL151 |
CHEMBL1794467
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL151 |
CHEMBL1052488
(1)
CHEMBL1052489
(1)
|
0 / 1 |
P14679 | Tyrosinase | Oxidoreductase | CHEMBL151 |
CHEMBL814347
(1)
|
4 / 2 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | CHEMBL151 |
CHEMBL1225718
(1)
CHEMBL1780346
(1)
|
4 / 4 |
P06276 | Cholinesterase | Hydrolase | CHEMBL151 |
CHEMBL1045780
(1)
|
0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | CHEMBL151 |
CHEMBL1614217
(1)
|
1 / 1 |
P04745 | Alpha-amylase 1 | Enzyme | CHEMBL151 |
CHEMBL964479
(2)
|
0 / 0 |
P45452 | Collagenase 3 | M10A | CHEMBL151 |
CHEMBL2051217
(1)
CHEMBL2051223
(1)
|
1 / 1 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | CHEMBL151 |
CHEMBL1614252
(2)
|
2 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL151 |
CHEMBL1225716
(1)
CHEMBL1741322
(1)
|
0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | CHEMBL151 |
CHEMBL2051213
(1)
CHEMBL2051219
(1)
|
1 / 3 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL151 |
CHEMBL1613910
(1)
CHEMBL1614227
(2)
|
3 / 3 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | CHEMBL151 |
CHEMBL1694230
(1)
CHEMBL2076243
(1)
CHEMBL2076821 (1) |
2 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL151 |
CHEMBL1614038
(1)
|
2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL151 |
CHEMBL1738588
(1)
CHEMBL1738317
(1)
|
0 / 0 |
Q9H2K2 | Tankyrase-2 | Enzyme | CHEMBL151 |
CHEMBL2341186
(2)
|
0 / 0 |
O14763 | Tumor necrosis factor receptor superfamily member 10B | Unclassified protein | CHEMBL151 |
CHEMBL1693928
(1)
|
1 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL151 |
CHEMBL999944
(1)
|
1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL151 |
CHEMBL1045781
(1)
|
1 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL151 |
CHEMBL1614240
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL151 |
CHEMBL1613777
(1)
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL151 |
CHEMBL1614108
(2)
CHEMBL1613886
(2)
CHEMBL1741324 (1) |
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL151 |
CHEMBL1794483
(2)
|
0 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | CHEMBL151 |
CHEMBL2173401
(1)
CHEMBL2173408
(1)
|
2 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL151 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL151 |
CHEMBL1614211
(4)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL151 |
CHEMBL1614421
(2)
CHEMBL1614502
(2)
|
4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL151 |
CHEMBL1738184
(1)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL151 |
CHEMBL1052486
(1)
|
3 / 4 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL151 |
CHEMBL941407
(1)
|
0 / 1 |
Q04760 | Lactoylglutathione lyase | Enzyme | CHEMBL151 |
CHEMBL967534
(1)
|
0 / 0 |
P08254 | Stromelysin-1 | M10A | CHEMBL151 |
CHEMBL2051214
(1)
CHEMBL2051220
(1)
|
1 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL151 |
CHEMBL1794536
(5)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL151 |
CHEMBL1613914
(3)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL151 |
CHEMBL1613829
(4)
CHEMBL1613928
(1)
CHEMBL1794433 (1) |
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL151 |
CHEMBL1738442
(1)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL151 |
CHEMBL1614364
(2)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL151 |
CHEMBL1614257
(3)
CHEMBL1614531
(2)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL151 |
CHEMBL1614257
(3)
CHEMBL1614531
(2)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL151 |
CHEMBL1613933
(2)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL151 |
CHEMBL1613933
(2)
|
1 / 6 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | CHEMBL151 |
CHEMBL832848
(1)
|
0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | CHEMBL151 |
CHEMBL832848
(1)
|
0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | CHEMBL151 |
CHEMBL832848
(1)
|
0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | CHEMBL151 |
CHEMBL832848
(1)
|
0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | CHEMBL151 |
CHEMBL832706
(1)
|
0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL151 |
CHEMBL832706
(1)
|
0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL151 |
CHEMBL2114738
(1)
|
0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | CHEMBL151 |
CHEMBL2114796
(1)
|
2 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D047311 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | Luteolin results in decreased activity of ABCC1 protein |
decreases activity
|
protein |
15670588
|
D047311 | 9429 |
ABCG2
ABC15 ABCP BCRP BCRP1 BMDP CD338 CDw338 EST157481 GOUT1 MRX MXR MXR1 UAQTL1 |
ATP-binding cassette, sub-family G (WHITE), member 2 | Luteolin affects the activity of ABCG2 protein |
affects activity
|
protein |
20403331
|
D047311 | 177 |
AGER
RAGE |
advanced glycosylation end product-specific receptor | Luteolin inhibits the reaction [Glucose results in increased expression of AGER mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D047311 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | Luteolin binds to and results in decreased activity of AHR protein |
affects binding
/ decreases activity |
protein |
14644660
|
D047311 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22926442
|
D047311 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | Luteolin results in decreased expression of AKT1 protein |
decreases expression
|
protein |
22926442
|
D047311 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | Luteolin results in increased expression of BAX protein |
increases expression
|
protein |
21601631
|
D047311 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] |
decreases expression
/ decreases reaction / increases degradation |
protein |
19557821
|
D047311 | 598 |
BCL2L1
BCL-XL/S BCL2L BCLX BCLXL BCLXS Bcl-X PPP1R52 bcl-xL bcl-xS |
BCL2-like 1 | Luteolin results in decreased expression of BCL2L1 protein |
decreases expression
|
protein |
21601631
|
D047311 | 329 |
BIRC2
API1 HIAP2 Hiap-2 MIHB RNF48 c-IAP1 cIAP1 |
baculoviral IAP repeat containing 2 | Luteolin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] |
decreases reaction
/ increases expression |
protein |
15334063
|
D047311 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein] |
increases activity
/ increases reaction |
protein |
16140950
|
D047311 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Luteolin results in increased activity of CASP3 protein |
increases activity
|
protein |
21074525
21601631 |
D047311 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Luteolin results in increased cleavage of CASP3 protein |
increases cleavage
|
protein |
18331776
19397994 |
D047311 | 840 |
CASP7
CASP-7 CMH-1 ICE-LAP3 LICE2 MCH3 |
caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | Luteolin results in increased activity of CASP7 protein |
increases activity
|
protein |
21074525
|
D047311 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | Luteolin promotes the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP8 protein] |
increases activity
/ increases cleavage / increases reaction |
protein |
15334063
|
D047311 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] |
increases activity
/ increases reaction |
protein |
16140950
|
D047311 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Luteolin results in increased activity of CASP9 protein |
increases activity
|
protein |
21601631
|
D047311 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Luteolin results in increased cleavage of CASP9 protein |
increases cleavage
|
protein |
18331776
19397994 |
D047311 | 847 |
CAT
|
catalase (EC:1.11.1.6) | Luteolin affects the activity of CAT protein |
affects activity
|
protein |
18503759
|
D047311 | 890 |
CCNA2
CCN1 CCNA |
cyclin A2 | Luteolin results in decreased expression of CCNA2 protein |
decreases expression
|
protein |
22926442
|
D047311 | 891 |
CCNB1
CCNB |
cyclin B1 | Luteolin results in decreased expression of CCNB1 mRNA |
decreases expression
|
mRNA |
18331776
19397994 |
D047311 | 891 |
CCNB1
CCNB |
cyclin B1 | Luteolin results in decreased expression of CCNB1 protein |
decreases expression
|
protein |
18331776
19397994 22926442 |
D047311 | 958 |
CD40
Bp50 CDW40 TNFRSF5 p50 |
CD40 molecule, TNF receptor superfamily member 5 | Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] |
affects cotreatment
/ decreases reaction / increases expression |
protein |
16601352
|
D047311 | 958 |
CD40
Bp50 CDW40 TNFRSF5 p50 |
CD40 molecule, TNF receptor superfamily member 5 | Luteolin inhibits the reaction [Calcimycin results in increased expression of CD40 protein] |
decreases reaction
/ increases expression |
protein |
16601352
|
D047311 | 958 |
CD40
Bp50 CDW40 TNFRSF5 p50 |
CD40 molecule, TNF receptor superfamily member 5 | Luteolin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD40 protein] |
decreases reaction
/ increases expression |
protein |
16601352
|
D047311 | 972 |
CD74
DHLAG HLADG II Ia-GAMMA |
CD74 molecule, major histocompatibility complex, class II invariant chain | Luteolin results in decreased expression of CD74 mRNA |
decreases expression
|
mRNA |
18818744
|
D047311 | 983 |
CDK1
CDC2 CDC28A P34CDC2 |
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | Luteolin results in decreased expression of CDK1 protein |
decreases expression
|
protein |
22926442
|
D047311 | 1017 |
CDK2
p33(CDK2) |
cyclin-dependent kinase 2 (EC:2.7.11.22) | Luteolin results in decreased activity of CDK2 protein |
decreases activity
|
protein |
11322924
|
D047311 | 1017 |
CDK2
p33(CDK2) |
cyclin-dependent kinase 2 (EC:2.7.11.22) | Luteolin results in decreased expression of CDK2 protein |
decreases expression
|
protein |
22926442
|
D047311 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Luteolin results in increased expression of CDKN1A mRNA |
increases expression
|
mRNA |
19397994
|
D047311 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Luteolin results in increased expression of CDKN1A protein |
increases expression
|
protein |
11322924
11790449 19397994 22926442 |
D047311 | 1027 |
CDKN1B
CDKN4 KIP1 MEN1B MEN4 P27KIP1 |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) | Luteolin results in increased expression of CDKN1B protein |
increases expression
|
protein |
11322924
|
D047311 | 1031 |
CDKN2C
INK4C p18 p18-INK4C |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | Luteolin results in decreased expression of CDKN2C mRNA |
decreases expression
|
mRNA |
18331776
|
D047311 | 1437 |
CSF2
GMCSF |
colony stimulating factor 2 (granulocyte-macrophage) | Luteolin results in decreased expression of CSF2 mRNA |
decreases expression
|
mRNA |
10718847
|
D047311 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Luteolin inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
20403331
|
D047311 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Luteolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17090139
|
D047311 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Luteolin results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
21482471
|
D047311 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Luteolin results in increased expression of CYP1A1 mRNA |
increases expression
|
mRNA |
20403331
|
D047311 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Luteolin results in decreased activity of CYP1B1 protein |
decreases activity
|
protein |
21482471
|
D047311 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Luteolin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 1-hydroxymethylmidazolam] |
decreases reaction
/ increases chemical synthesis |
protein |
18191104
|
D047311 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | Luteolin inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 4-hydroxymidazolam] |
decreases reaction
/ increases chemical synthesis |
protein |
18191104
|
D047311 | 1577 |
CYP3A5
CP35 CYPIIIA5 P450PCN3 PCN3 |
cytochrome P450, family 3, subfamily A, polypeptide 5 (EC:1.14.14.1) | Luteolin inhibits the reaction [CYP3A5 protein results in increased chemical synthesis of 4-hydroxymidazolam] |
decreases reaction
/ increases chemical synthesis |
protein |
18191104
|
D047311 | 1950 |
EGF
HOMG4 URG |
epidermal growth factor | EGF protein inhibits the reaction [Luteolin results in decreased phosphorylation of PTK2 protein] |
decreases phosphorylation
/ decreases reaction |
protein |
15135307
|
D047311 | 1950 |
EGF
HOMG4 URG |
epidermal growth factor | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22926442
|
D047311 | 1950 |
EGF
HOMG4 URG |
epidermal growth factor | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15135307
|
D047311 | 1950 |
EGF
HOMG4 URG |
epidermal growth factor | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
decreases reaction
/ increases phosphorylation |
protein |
22926442
|
D047311 | 1950 |
EGF
HOMG4 URG |
epidermal growth factor | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15135307
|
D047311 | 1950 |
EGF
HOMG4 URG |
epidermal growth factor | Luteolin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein] |
decreases reaction
/ increases secretion |
protein |
15135307
|
D047311 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of EGFR protein] |
decreases reaction
/ increases activity / increases phosphorylation |
protein |
15135307
|
D047311 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
decreases reaction
/ increases phosphorylation |
protein |
22926442
|
D047311 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | Luteolin results in decreased expression of EGFR mRNA |
decreases expression
|
mRNA |
22926442
|
D047311 | 1956 |
EGFR
ERBB ERBB1 HER1 PIG61 mENA |
epidermal growth factor receptor (EC:2.7.10.1) | Luteolin results in decreased phosphorylation of and results in increased activity of EGFR protein |
decreases phosphorylation
/ increases activity |
protein |
15135307
|
D047311 | 1958 |
EGR1
AT225 G0S30 KROX-24 NGFI-A TIS8 ZIF-268 ZNF225 |
early growth response 1 | Luteolin results in increased expression of EGR1 mRNA |
increases expression
|
mRNA |
19397994
|
D047311 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Luteolin binds to ESR1 protein |
affects binding
|
protein |
14579009
|
D047311 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Luteolin inhibits the reaction [Estradiol binds to ESR1 protein] |
affects binding
/ decreases reaction |
protein |
14579009
|
D047311 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Luteolin binds to ESR2 protein |
affects binding
|
protein |
12224631
|
D047311 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Luteolin results in increased activity of ESR2 protein |
increases activity
|
protein |
16860978
|
D047311 | 2203 |
FBP1
FBP |
fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) | Luteolin results in decreased expression of FBP1 mRNA |
decreases expression
|
mRNA |
18331776
|
D047311 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | Luteolin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
15322261
|
D047311 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | Luteolin inhibits the reaction [TNF protein results in increased expression of FOS mRNA] |
decreases reaction
/ increases expression |
mRNA |
15322261
|
D047311 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | Luteolin results in decreased activity of FOS protein |
decreases activity
|
protein |
16343431
|
D047311 | 2354 |
FOSB
AP-1 G0S3 GOS3 GOSB |
FBJ murine osteosarcoma viral oncogene homolog B | Luteolin results in decreased activity of FOSB protein |
decreases activity
|
protein |
16343431
|
D047311 | 4616 |
GADD45B
GADD45BETA MYD118 |
growth arrest and DNA-damage-inducible, beta | Luteolin results in increased expression of GADD45B mRNA |
increases expression
|
mRNA |
18331776
|
D047311 | 4616 |
GADD45B
GADD45BETA MYD118 |
growth arrest and DNA-damage-inducible, beta | Luteolin results in increased expression of GADD45B protein |
increases expression
|
protein |
18331776
|
D047311 | 3383 |
ICAM1
BB2 CD54 P3.58 |
intercellular adhesion molecule 1 | Luteolin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15113938
15322261 |
D047311 | 3383 |
ICAM1
BB2 CD54 P3.58 |
intercellular adhesion molecule 1 | Luteolin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
15322261 |
D047311 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Luteolin inhibits the reaction [Glucose results in increased expression of IL1B mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D047311 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Luteolin inhibits the reaction [Glucose results in increased expression of IL1B protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D047311 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4] |
affects cotreatment
/ decreases reaction / increases expression |
16601352
|
|
D047311 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | Luteolin results in decreased expression of IL4 protein |
decreases expression
|
protein |
16343431
|
D047311 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Luteolin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
15322261
|
D047311 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Luteolin inhibits the reaction [TNF protein results in increased expression of JUN mRNA] |
decreases reaction
/ increases expression |
mRNA |
15322261
|
D047311 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Luteolin promotes the reaction [TNF protein results in increased phosphorylation of JUN protein] |
increases phosphorylation
/ increases reaction |
protein |
15334063
|
D047311 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | Luteolin results in decreased phosphorylation of and results in decreased activity of JUN protein |
decreases activity
/ decreases phosphorylation |
protein |
16343431
|
D047311 | 3726 |
JUNB
AP-1 |
jun B proto-oncogene | Luteolin results in decreased activity of JUNB protein |
decreases activity
|
protein |
16343431
|
D047311 | 3727 |
JUND
AP-1 |
jun D proto-oncogene | Luteolin results in decreased activity of JUND protein |
decreases activity
|
protein |
16343431
|
D047311 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19557821
|
D047311 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Luteolin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
15322261
|
D047311 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Luteolin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein |
decreases activity
/ decreases phosphorylation |
protein |
10718847
|
D047311 | 5602 |
MAPK10
JNK3 JNK3A PRKM10 SAPK1b p493F12 p54bSAPK |
mitogen-activated protein kinase 10 (EC:2.7.11.24) | Luteolin results in increased phosphorylation of MAPK10 protein |
increases phosphorylation
|
protein |
21601631
|
D047311 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Luteolin inhibits the reaction [Glucose results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
19557821
|
D047311 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Luteolin results in decreased phosphorylation of and results in decreased activity of MAPK3 protein |
decreases activity
/ decreases phosphorylation |
protein |
10718847
|
D047311 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | Luteolin promotes the reaction [TNF protein results in increased phosphorylation of MAPK8 protein] |
increases phosphorylation
/ increases reaction |
protein |
15334063
|
D047311 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | Luteolin results in decreased phosphorylation of and results in decreased activity of MAPK8 protein |
decreases activity
/ decreases phosphorylation |
protein |
10718847
|
D047311 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | Luteolin results in increased phosphorylation of MAPK8 protein |
increases phosphorylation
|
protein |
21601631
|
D047311 | 5601 |
MAPK9
JNK-55 JNK2 JNK2A JNK2ALPHA JNK2B JNK2BETA PRKM9 SAPK SAPK1a p54a p54aSAPK |
mitogen-activated protein kinase 9 (EC:2.7.11.24) | Luteolin results in increased phosphorylation of MAPK9 protein |
increases phosphorylation
|
protein |
21601631
|
D047311 | 4312 |
MMP1
CLG CLGN |
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) | Luteolin results in decreased expression of MMP1 mRNA |
decreases expression
|
mRNA |
21112745
|
D047311 | 4312 |
MMP1
CLG CLGN |
matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) | Luteolin results in decreased expression of MMP1 protein |
decreases expression
|
protein |
21112745
|
D047311 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | Luteolin inhibits the reaction [EGF protein results in increased secretion of MMP9 protein] |
decreases reaction
/ increases secretion |
protein |
15135307
|
D047311 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | Luteolin results in decreased secretion of MMP9 protein |
decreases secretion
|
protein |
15135307
|
D047311 | 4790 |
NFKB1
EBP-1 KBF1 NF-kB1 NF-kappa-B NF-kappaB NFKB-p105 NFKB-p50 NFkappaB p105 p50 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Luteolin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] |
decreases reaction
/ increases activity |
protein |
15334063
|
D047311 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of NFKBIA protein] |
decreases expression
/ decreases reaction / increases degradation |
protein |
19557821
|
D047311 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Luteolin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein] |
decreases reaction
/ increases degradation |
protein |
15322261
|
D047311 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Luteolin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]] |
affects binding
/ decreases reaction / increases phosphorylation |
protein |
15322261
|
D047311 | 4793 |
NFKBIB
IKBB TRIP9 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | Luteolin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]] |
affects binding
/ decreases reaction / increases phosphorylation |
protein |
15322261
|
D047311 | 9572 |
NR1D1
EAR1 THRA1 THRAL ear-1 hRev |
nuclear receptor subfamily 1, group D, member 1 | Luteolin results in decreased expression of NR1D1 mRNA |
decreases expression
|
mRNA |
19397994
|
D047311 | 5347 |
PLK1
PLK STPK13 |
polo-like kinase 1 (EC:2.7.11.21) | Luteolin results in decreased expression of PLK1 protein |
decreases expression
|
protein |
22926442
|
D047311 | 8000 |
PSCA
PRO232 |
prostate stem cell antigen | Luteolin results in decreased expression of PSCA mRNA |
decreases expression
|
mRNA |
18331776
19397994 |
D047311 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D047311 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D047311 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | EGF protein inhibits the reaction [Luteolin results in decreased phosphorylation of PTK2 protein] |
decreases phosphorylation
/ decreases reaction |
protein |
15135307
|
D047311 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | Luteolin inhibits the reaction [EGF protein results in increased phosphorylation of PTK2 protein] |
decreases reaction
/ increases phosphorylation |
protein |
15135307
|
D047311 | 5747 |
PTK2
FADK FAK FAK1 FRNK PPP1R71 p125FAK pp125FAK |
protein tyrosine kinase 2 (EC:2.7.10.2) | Luteolin results in decreased phosphorylation of PTK2 protein |
decreases phosphorylation
|
protein |
15135307
|
D047311 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Luteolin inhibits the reaction [Glucose affects the localization of RELA protein] |
affects localization
/ decreases reaction |
protein |
19557821
|
D047311 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Luteolin inhibits the reaction [TNF protein affects the localization of RELA protein] |
affects localization
/ decreases reaction |
protein |
15113938
|
D047311 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Luteolin inhibits the reaction [TNF protein results in increased activity of RELA protein] |
decreases reaction
/ increases activity |
protein |
15334063
|
D047311 | 6401 |
SELE
CD62E ELAM ELAM1 ESEL LECAM2 |
selectin E | Luteolin inhibits the reaction [TNF protein results in increased expression of SELE mRNA] |
decreases reaction
/ increases expression |
mRNA |
15113938
|
D047311 | 6401 |
SELE
CD62E ELAM ELAM1 ESEL LECAM2 |
selectin E | Luteolin inhibits the reaction [TNF protein results in increased expression of SELE protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047311 | 2810 |
SFN
YWHAS |
stratifin | Luteolin results in increased expression of SFN mRNA |
increases expression
|
mRNA |
18331776
|
D047311 | 2810 |
SFN
YWHAS |
stratifin | Luteolin results in increased expression of SFN protein |
increases expression
|
protein |
18331776
|
D047311 | 6647 |
SOD1
ALS ALS1 IPOA SOD hSod1 homodimer |
superoxide dismutase 1, soluble (EC:1.15.1.1) | Luteolin affects the activity of SOD1 protein |
affects activity
|
protein |
18503759
|
D047311 | 29110 |
TBK1
NAK T2K |
TANK-binding kinase 1 (EC:2.7.11.1) | Luteolin results in decreased activity of TBK1 protein |
decreases activity
|
protein |
19426678
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [Glucose results in increased expression of TNF mRNA] |
decreases reaction
/ increases expression |
mRNA |
19557821
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [Glucose results in increased expression of TNF protein] |
decreases reaction
/ increases expression |
protein |
19557821
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein affects the localization of RELA protein] |
affects localization
/ decreases reaction |
protein |
15113938
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
15322261
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
15322261
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein] |
decreases reaction
/ increases activity |
protein |
15334063
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased activity of RELA protein] |
decreases reaction
/ increases activity |
protein |
15334063
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein] |
decreases reaction
/ increases degradation |
protein |
15322261
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of BIRC2 protein] |
decreases reaction
/ increases expression |
protein |
15334063
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of FOS mRNA] |
decreases reaction
/ increases expression |
protein |
15322261
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] |
decreases reaction
/ increases expression |
protein |
15113938
15322261 |
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
15322261 |
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of JUN mRNA] |
decreases reaction
/ increases expression |
protein |
15322261
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of SELE mRNA] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of SELE protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
decreases reaction
/ increases expression |
protein |
15334063
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin inhibits the reaction [TNF protein results in increased phosphorylation of [NFKBIB protein binds to NFKBIA protein]] |
affects binding
/ decreases reaction / increases phosphorylation |
protein |
15322261
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin promotes the reaction [TNF protein results in increased cleavage of and results in increased activity of CASP8 protein] |
increases activity
/ increases cleavage / increases reaction |
protein |
15334063
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin promotes the reaction [TNF protein results in increased phosphorylation of JUN protein] |
increases phosphorylation
/ increases reaction |
protein |
15334063
|
D047311 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Luteolin promotes the reaction [TNF protein results in increased phosphorylation of MAPK8 protein] |
increases phosphorylation
/ increases reaction |
protein |
15334063
|
D047311 | 7128 |
TNFAIP3
A20 OTUD7C TNFA1P2 |
tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) | Luteolin inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
decreases reaction
/ increases expression |
protein |
15334063
|
D047311 | 8743 |
TNFSF10
APO2L Apo-2L CD253 TL2 TRAIL |
tumor necrosis factor (ligand) superfamily, member 10 | Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP3 protein] |
increases activity
/ increases reaction |
protein |
16140950
|
D047311 | 8743 |
TNFSF10
APO2L Apo-2L CD253 TL2 TRAIL |
tumor necrosis factor (ligand) superfamily, member 10 | Luteolin promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein] |
increases activity
/ increases reaction |
protein |
16140950
|
D047311 | 8743 |
TNFSF10
APO2L Apo-2L CD253 TL2 TRAIL |
tumor necrosis factor (ligand) superfamily, member 10 | Luteolin promotes the reaction [TNFSF10 protein results in increased ubiquitination of and results in increased degradation of and results in decreased expression of XIAP protein] |
decreases expression
/ increases degradation / increases reaction / increases ubiquitination |
protein |
16140950
|
D047311 | 9540 |
TP53I3
PIG3 |
tumor protein p53 inducible protein 3 | Luteolin results in increased expression of TP53I3 mRNA |
increases expression
|
mRNA |
18331776
19397994 |
D047311 | 9540 |
TP53I3
PIG3 |
tumor protein p53 inducible protein 3 | Luteolin results in increased expression of TP53I3 protein |
increases expression
|
protein |
18331776
19397994 |
D047311 | 8626 |
TP63
AIS B(p51A) B(p51B) EEC3 KET LMS NBP OFC8 RHS SHFM4 TP53CP TP53L TP73L p40 p51 p53CP p63 p73H p73L |
tumor protein p63 | Luteolin results in increased expression of TP63 protein |
increases expression
|
protein |
18331776
19397994 |
D047311 | 7161 |
TP73
P73 |
tumor protein p73 | Luteolin results in increased expression of TP73 protein |
increases expression
|
protein |
18331776
19397994 |
D047311 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | Luteolin inhibits the reaction [Benzo(a)pyrene results in increased expression of UGT1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
20403331
|
D047311 | 54659 |
UGT1A3
UDPGT UDPGT_1-3 UGT-1C UGT1-03 UGT1.3 UGT1C |
UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | UGT1A3 mutant form affects the glucuronidation of Luteolin |
affects glucuronidation
|
mutant form |
16738032
|
D047311 | 54659 |
UGT1A3
UDPGT UDPGT_1-3 UGT-1C UGT1-03 UGT1.3 UGT1C |
UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | UGT1A3 protein results in increased glucuronidation of Luteolin |
increases glucuronidation
|
protein |
16738032
|
D047311 | 10451 |
VAV3
|
vav 3 guanine nucleotide exchange factor | Luteolin results in decreased expression of VAV3 mRNA |
decreases expression
|
mRNA |
19397994
|
D047311 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Luteolin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15113938
|
D047311 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Luteolin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
15113938
|
D047311 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Luteolin results in decreased expression of VEGFA mRNA |
decreases expression
|
mRNA |
19005980
|
D047311 | 7422 |
VEGFA
MVCD1 VEGF VPF |
vascular endothelial growth factor A | Luteolin results in decreased expression of VEGFA protein |
decreases expression
|
protein |
19005980
|
D047311 | 8839 |
WISP2
CCN5 CT58 CTGF-L |
WNT1 inducible signaling pathway protein 2 | Luteolin results in decreased expression of WISP2 mRNA |
decreases expression
|
mRNA |
19397994
|
D047311 | 331 |
XIAP
API3 BIRC4 IAP-3 ILP1 MIHA XLP2 hIAP-3 hIAP3 |
X-linked inhibitor of apoptosis | Luteolin promotes the reaction [TNFSF10 protein results in increased ubiquitination of and results in increased degradation of and results in decreased expression of XIAP protein] |
decreases expression
/ increases degradation / increases reaction / increases ubiquitination |
protein |
16140950
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#114500 | Colorectal cancer; crc |
P18054
P84022 Q14191 |
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#230200 | Galactokinase deficiency |
P51570
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#167000 | Ovarian cancer |
P38398
|
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
O14763
P04637 |
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q15046 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) |
H00028 | Choriocarcinoma |
P03956
(related)
P04637 (related) P08253 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00027 | Ovarian cancer |
P04637
(related)
P38398 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
P38398 (related) |
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00192 | Xanthinuria |
P47989
(related)
|
H00070 | Galactosemia |
P51570
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D009202 | D047311 | Cardiomyopathies |
therapeutic
|
9242351
|
|
D002386 | D047311 | Cataract |
therapeutic
|
22342831
|
|
D005483 | D047311 | Flushing |
therapeutic
|
18223672
|
|
D006529 | D047311 | Hepatomegaly |
therapeutic
|
19747501
|
|
D008103 | D047311 | Liver Cirrhosis |
therapeutic
|
19747501
|
|
D010051 | D047311 | Ovarian Neoplasms |
therapeutic
|
19005980
|